The global radiotherapy market size, valued at USD 3.69 billion in 2024, is expected to reach USD 3.80 billion in 2025 and USD 5.0 billion by 2035, representing a CAGR of 2.78% during the forecast period. In a recent report of WHO, nearly 2.3 million women has been diagnosed with breast cancer and around 6,70,000 deaths occurred globally due to breast cancer. This increasing prevalence of cancer has underscored the requirement for advanced radiotherapy treatment with higher efficacy rate and min...

The global medical cannabis market, valued at USD 21.33 billion in 2024, is poised to reach USD 27.81 billion in 2025 and USD 211.54 billion by 2035, representing a CAGR of 22.5% during the forecast period. It is important to highlight here that In October 2024, Releaf (UK

The global needle-free drug injection system market size is estimated to rise from $2,720 million currently to $5,031 million by 2035, growing at a CAGR of 5.8% during the forecast period till 2035. Based on the route of administration, the global needle-free injection system market is categorized into subcutaneous, intramuscular and intradermal routes. Subcutaneous route segment occupies the highest share (55%) and is expected to witness substantial growth in the coming years. With the potentia...

The global joint pain injections market, valued at USD 5.75 billion in 2024, is projected to reach USD 6.23 billion in 2025 and USD 12.09 billion by 2035, representing a CAGR of 6.9% during the forecast period. As per the report of the World Health Organization, osteoarthritis is getting more prevalent among aged people (nearly 70% of people, about 55 years of age). Among these, nearly 60% of the population with osteoarthritis are women. Moreover, people specifically athletes and individual with...

The global sports medicine market is currently valued at USD 6.30 billion in 2024 and is expected to reach USD 6.78 billion in 2025 and USD 12.33 billion by 2035, representing a compounded annual growth rate (CAGR) of 6.2% during the forecast period. A recent report published by National Institute of Health stated that in 2024, athletic trainers reported around 15,631 injuries during 6,778,209 athletic exposures. Notably, the most common injured areas of the body due to sports activities include...

The global human factors and usability engineering services market, valued at USD 1.01 billion in 2025, is projected to reach USD 1.09 billion in 2026 and USD 1.97 billion by 2035, representing a CAGR of 6.7% during the forecast period. Market growth over the next decade is expected to be driven by increased technological innovations leading to the development of complex medical devices that require stringent regulatory review. Further, the heightened focus on user’s safety along with the need...

The global non-muscle invasive bladder cancer market, valued at USD 2.92 billion in 2024, is projected to reach USD 3.47 billion in 2025 and USD 14.01 billion by 2035, representing a CAGR of 15.0% during the forecast period. Non-muscle invasive bladder cancer (NMIBC) is a form of early-stage cancer that remains confined to the inner linings of the bladder. Recently, there has been a surge in the cases of non-muscle invasive bladder cancer among the population worldwide. A recent report by ACS es...

The global nutraceuticals market, valued at USD 483.49 billion in 2024, is projected to reach USD 521.04 billion in 2025 and USD 969.11 billion by 2035, representing a CAGR of 6.4% during the forecast period. According to the recent report published by World Health Organization, nearly 830 million people globally have diabetes and approximately half of the people with diabetes are not receiving any treatment. In addition to diabetes, obesity is one of the most prevailing condition across the glo...

The antimicrobial resistance surveillance market is valued at USD 6.64 billion in 2025 and is estimated to reach USD 11.32 billion by 2035, representing a higher CAGR of 5.47% during the forecast period. Antimicrobial resistance has become a major concern for healthcare experts as it creates challenges in the treatment of patients. As per the report of Centers for Disease Control and Prevention, over 2.8 million antimicrobial-resistance infections occur annually in the US. Moreover, the World H...

The global cannabis market, valued at USD 39.21 billion in 2024, is expected to reach USD 47.76 billion in 2025 and USD 231.81 billion by 2035, representing a healthy CAGR of 17.1% during the forecast period. It is important to highlight here that cannabis industrial players and several government organizations are making considerable investments in this field to promote the legal adoption of cannabis for medicinal and recreational purposes. For instance, in June 2024, New York City Economic Dev...

The global companion animal health market size, valued at USD 24.50 billion in 2024, is projected to reach USD 26.53 billion in 2025 and USD 51.45 billion by 2035, representing a CAGR of 6.8% during the forecast period. In April 2024, European Commission announced the European Partnership for Animal Health and Welfare. Under this partnership 56 European research institutes and 30 funding organizations along with Austrian Science Fund teamed up to combat the risk of infectious diseases in animals...

The global cannabidiol oil market, valued at USD 7.22 billion in 2024, is estimated to grow to USD 8.89 billion in 2025 and USD 50.05 billion by 2035, representing a higher CAGR of 18.86% during the forecast period. On the basis of the type of product, the global cannabidiol oil market is segmented into original oil and blended oil. Among these, currently original oil accounts for the highest share (nearly 65%) of the market. This dominance is due to the fact that original oil has high concentra...

The global sterile injectable contract manufacturing market is expected to grow from USD 14.4 billion in 2024 to USD 33.7 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 8% during the forecast period. Examples of the leading companies engaged in this industry (the complete list of key players has also been listed in the detailed report) include Aenova Group, Baxter, Boehringer Ingelheim, Catalent, Cipla, Fresenius Kabi, Famar, Grifols, NextPharma Technologies...

The global gene therapy market, valued at USD 4.20 billion in 2025, is projected to reach USD 6.07 billion in 2026 and USD 20.47 billion by 2035, with a 14.5% CAGR during the forecast period 2026 to 2035. According to the World Health Organization (WHO), 10 out of every 1,000 individuals are affected by genetic disorders, with over 70 million people worldwide living with such conditions. In fact, more than 40% of infant mortality globally is associated with various genetic disorders. Therefore...

The global DNA vaccine market size is estimated to be USD 552.43 million in 2025 and is poised to reach USD 1,036.35 million by 2035, representing a CAGR of 6.49% during the forecast period. Currently, vector borne diseases accounts for the highest DNA vaccine market share. This can be attributed to the growing clinical trial pipeline for treating vector borne diseases such as dengue, malaria, chikungunya and Zika virus. It is important to highlight here that a group of researchers published res...

The CRISPR market size is projected to grow from USD 2.87 billion in 2025 to USD 12.22 billion by 2035, representing a CAGR of 15.60% during the forecast period till 2035. In September 2024, Pairwise secured USD 40 million in Series C funding to advance gene editing in plant breeding. This funding was led by Deerfield Management and other returning investors along with new investor Corteva. Overall, the future of CRISPR is promising however, regulatory uncertainties and complexity in off-target...

The global cannabis cultivation market, valued at USD 554.42 billion in 2024, is projected to grow to USD 690.33 billion in 2025 and USD 3,257.54 billion by 2035, representing a CAGR of 16.8% during the forecast period. Besides the medicinal usage, cannabis derivatives, such as tinctures and cannabidiol (CBD) oil has been widely used in skincare products including creams, oils and capsules to treat skin conditions (eczema, skin redness and breakouts). For instance, in February 2024, Jublee launc...

The global compounding pharmacy market size is estimated to grow from USD 15.6 billion in 2024 to USD 31.8 billion by 2035, representing a higher compounded annual growth rate (CAGR) of ~7% during the forecast period, till 2035. It is worth highlighting here that compound pharmacies have also provided access to various discontinued medications specifically due to commercial reasons. Although therapeutic drugs have been commercialized after successful clinical trials, ensuring complete efficiency...

The global whole genome sequencing market size is estimated at USD 2.63 billion in 2025 and is poised to reach USD 13.62 billion by 2035; expected to grow at a CAGR of 17.9%. In January 2025, Ovation.io announced the launch of a research dataset which combines WGS data and the clinical records of the patients treated by GLP-1 agonists. Additionally, in October 2024, Bupa becomes the first-of-its kind private healthcare provider of UK to pilot whole genome sequencing for selected customers to ide...

The global vaccine contract manufacturing market size, valued at USD 2.25 billion in 2025, is projected to reach USD 2.40 billion in 2026 and USD 4.75 billion by 2035, representing a CAGR of 7.9% during the forecast period. Currently, the mammalian market segment captures maximum share (60%) of the overall market; and this trend is unlikely to change in the future as well. This can be attributed to the fact that vaccines produced in mammalian cells often exhibit higher biological activity and bi...